Brooke Czapkowski is the Global Submissions Manager for Worldwide Regulatory Operations at Pfizer. Brooke has 5+ years of ADC experience, spanning multiple specialties, including conjugating, purifying and filtering ADCs, lysine and cysteine based conjugation chemistries and performing multivariate analyses of her experiments. In her tenure at Pfizer, she has managed projects in both development and manufacturing arenas, including both drug substance and drug product for various ADC products for both clinical and commercial markets.
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.